HOXB7 and cervical cancer: Zhao et al. demonstrated that hsa-circ-0009035 can target the miR-889-3p/HOXB7 axis as an important regulator of cervical cancer progression and radioresistance by exerting a competitive endogenous role, which can become a potential therapeutic target for cervical cancer therapy.